LIABILITY FOR GENERIC SUBSTITUTION

被引：2
|
作者：
GORDINIER, RH
机构：
来源：
POSTGRADUATE MEDICINE | 1987年 / 81卷 / 03期
关键词：
D O I：
10.1080/00325481.1987.11699719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / &
相关论文
共 50 条
  • [31] BRAND NAMES, GENERIC PRESCRIBING, AND GENERIC SUBSTITUTION
    PINCUS, RC
    MEDICAL JOURNAL OF AUSTRALIA, 1983, 2 (02) : 89 - 91
  • [32] LIABILITY IN DRUG SUBSTITUTION AT THE HOSPITAL
    RIEGER, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (04) : 121 - 122
  • [33] LIABILITY OF CR(IV) TO SUBSTITUTION
    OGARD, AE
    TAUBE, H
    JOURNAL OF PHYSICAL CHEMISTRY, 1958, 62 (03): : 357 - 358
  • [34] Longitudinal Analysis of Generic Substitution
    Locatelli M.
    Strøm S.
    Atlantic Economic Journal, 2015, 43 (3) : 363 - 374
  • [35] GENERIC SUBSTITUTION - THE INDUSTRY REPLIES
    TOERIEN, JG
    SOUTH AFRICAN MEDICAL JOURNAL, 1984, 66 (22): : 831 - 832
  • [36] GENERIC SUBSTITUTION FOR PSYCHOTROPIC DRUGS
    Blier, Pierre
    CNS SPECTRUMS, 2009, 14 (09) : 2 - 7
  • [37] Generic Substitution for Immunosuppressive Drugs
    Helderman, J. Harold
    DIALYSIS & TRANSPLANTATION, 2011, 40 (01) : 37 - 40
  • [38] Substitution of Generic Drugs and BiosimilarsReply
    Sarpatwari, Ameet
    Kesselheim, Aaron S.
    Sacks, Chana A.
    JAMA INTERNAL MEDICINE, 2021, 181 (04) : 568 - 568
  • [39] BMAS VIEW ON GENERIC SUBSTITUTION
    RICHARDS, J
    BRITISH MEDICAL JOURNAL, 1992, 305 (6844): : 56 - 56
  • [40] GENERIC SUBSTITUTION: PHARMACOECONOMIC CONSEQUENCES
    Tomic, Z.
    Sabo, A.
    Vukmirovic, S.
    Milijasevic, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 99 - 100
12345